Sphere Medical based in Cambridge, UK received the European CE Mark of approval for its Proxima Generation 2 disposable arterial blood analyser. The device is intended for continuous monitoring of glucose, blood gas & electrolytes in patients in the OR and ICU and a recent clinical study has shown that the Proxima Generation 2 provides an equivalent performance when compared to lab and point-of-care blood gas analysers of arterial blood.
Because measurements are made on a continuous basis and all the blood is immediately returned to the patient, the device lets clinicians keep a steady eye on patients without having to take regular readings and run samples to the lab.
Press release: Proxima Generation 2 Achieves European CE Marking